StockTipsArenaBeta

BUY Thyrocare Technologies Limited — Sumeet Bagadia, Choice Broking

BUYThyrocare Technologies Limited
Thyrocare Technologies share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred 1–3 months)12 Aug 2026via LiveMint Buy-or-Sell (topic)

Entry₹649Stated
Target₹700
Total upside +7.86% (call closed)
Stop loss₹615-5.24% risk
Exit₹61513 Aug 2026, 12:08 pm
Stop-loss hit-5.24%
Follow Sumeet Bagadia for new calls(21% target hit, 39 closed calls)Get alertsWatch THYROCARE for new buy/sell callsGet alertsSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026
3 supporting2 neutral0 opposing
Supports the BUY call (3)

Thyrocare Block Deal: ₹1,000 cr stake sale likely; 1.5 crore shares at ₹630-631 floor price

NewsCnbc-Tv18·11 Aug · yesterday

(opens in new tab)

Thyrocare Technologies reported robust Q1FY27 results with revenue up 24% YoY to INR 240.02 Cr and PAT up 34% YoY to INR 51.33 Cr. The company also expanded into Specialty Diagnostics.

BSE · Company Update·23 Jul · 3w ago

(opens in new tab)

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·23 Jul · 3w ago

Neutral / worth noting (2)

Thyrocare Block Deal: Equity worth ₹793 crore changes hands in pre-open large trade

NewsCnbc-Tv18·13 Aug · today

(opens in new tab)

Thyrocare Technologies Ltd announced the outcome of its Board Meeting held on July 23, 2026. The board approved the unaudited financial results for the quarter ended June 30, 2026, along with the limi

BSE · Board Meeting·23 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Thyrocare Technologies

All analyst calls on Thyrocare Technologies

More from Sumeet Bagadia, Choice Broking

Every call and its outcome